Sinclair IS Pharma, Valeant Pharmaceuticals sales and marketing update

Valeant granted Sinclair exclusive rights to market three injectable aesthetic dermal filler products in Western Europe for €9 million ($11.6 million). The deal includes Sculptra, New-Fill and Succ...